1. Home
  2. KAPA vs NXGL Comparison

KAPA vs NXGL Comparison

Compare KAPA & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KAPA
  • NXGL
  • Stock Information
  • Founded
  • KAPA 2013
  • NXGL 1997
  • Country
  • KAPA United States
  • NXGL United States
  • Employees
  • KAPA N/A
  • NXGL N/A
  • Industry
  • KAPA
  • NXGL Medical/Dental Instruments
  • Sector
  • KAPA
  • NXGL Health Care
  • Exchange
  • KAPA NYSE
  • NXGL Nasdaq
  • Market Cap
  • KAPA 20.2M
  • NXGL 22.7M
  • IPO Year
  • KAPA 2024
  • NXGL 2021
  • Fundamental
  • Price
  • KAPA $1.60
  • NXGL $4.73
  • Analyst Decision
  • KAPA Strong Buy
  • NXGL
  • Analyst Count
  • KAPA 1
  • NXGL 0
  • Target Price
  • KAPA $9.00
  • NXGL N/A
  • AVG Volume (30 Days)
  • KAPA 92.8K
  • NXGL 168.1K
  • Earning Date
  • KAPA 11-14-2024
  • NXGL 11-13-2024
  • Dividend Yield
  • KAPA N/A
  • NXGL N/A
  • EPS Growth
  • KAPA N/A
  • NXGL N/A
  • EPS
  • KAPA N/A
  • NXGL N/A
  • Revenue
  • KAPA N/A
  • NXGL $6,729,000.00
  • Revenue This Year
  • KAPA N/A
  • NXGL $120.47
  • Revenue Next Year
  • KAPA N/A
  • NXGL $38.19
  • P/E Ratio
  • KAPA N/A
  • NXGL N/A
  • Revenue Growth
  • KAPA N/A
  • NXGL 90.57
  • 52 Week Low
  • KAPA $1.22
  • NXGL $1.84
  • 52 Week High
  • KAPA $4.00
  • NXGL $5.10
  • Technical
  • Relative Strength Index (RSI)
  • KAPA N/A
  • NXGL 66.45
  • Support Level
  • KAPA N/A
  • NXGL $4.11
  • Resistance Level
  • KAPA N/A
  • NXGL $5.10
  • Average True Range (ATR)
  • KAPA 0.00
  • NXGL 0.40
  • MACD
  • KAPA 0.00
  • NXGL 0.08
  • Stochastic Oscillator
  • KAPA 0.00
  • NXGL 78.98

About KAPA KAIROS PHARMA LTD

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.

About NXGL NexGel Inc

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.

Share on Social Networks: